HDAC8 (human), (recombinant) BML-SE145-0100 from Enzo Life Sciences, Inc.

Product Specs
ItemHDAC8 (human), (recombinant)
CompanyEnzo Life Sciences, Inc.
Price $404.00Supplier Page View Company Product Page
Catalog NumberBML-SE145-0100
Size100 U
FormatLiquid. In 10mM TRIS, pH 7.5, containing 100mM NaCl, 3mM MgCl₂ and 10% glycerol
Molecular Weight42 kDa
Molecule NameHDAC8 (human), (recombinant)
Source/Expression SystemProduced in E. coli. Recombinant HDAC8 from human cDNA (377 aa)
NCBI Full Gene Namehistone deacetylase 8
NCBI Gene AliasesCDA07, CDLS5, HD8, HDACL1, KDAC8, MRXS6, RPD3, WTS
TypeProtein

10 Executive Blvd.

Farmingdale, NY 11735

United States

Phone: 800-942-0430
Fax: 610-941-9252

(1) New 5-Aryl-Substituted 2-Aminobenzamide-Type HDAC Inhibitors with a Diketopiperazine Group and Their Ameliorating Effects on Ischemia-Induced Neuronal Cell DeathScientific ReportsDecember 1, 2018Yoshiyuki Hirata, Tsutomu Sasaki, Hideaki Kanki, Chi-Jing Choong, Kumiko Nishiyama, Genki Kubo, Ayana Hotei, Masahiko Taniguchi, Hideki Mochizuki, Shinichi UesatoFluorometric Drug Discovery Assay Kit BML-AK511 (HDAC1), BML-AK 512 (HDAC2), and BML-AK 531 (HDAC3), BML-SE145-0100 (HDAC8) and BML-SE508-0050 (HDAC6) (supplied from Enzo Life Sciences). The following two groups of experiments

HDAC8 (human), (recombinant) from Enzo Life Sciences, Inc.